GW501516X

GW501516X is a code name for an investigational drug studied for its effects on cardiac energy metabolism. Its precise chemical identity is not widely documented in primary literature, but its name suggests it may be an analog, isomer, or related compound to GW501516 (cardarine), a selective agonist of the peroxisome proliferator-activated receptor delta (PPARδ). GW501516 and related agonists modulate energy metabolism through PPARδ activation, upregulating genes involved in fatty acid oxidation and mitochondrial biogenesis, with the effect of shifting substrate utilization in muscle and potentially heart tissue from glucose to fatty acids. The main indication explored in clinical research (as per one registered trial) is the regulation of cardiac metabolism[4]. There is no evidence that GW501516X is approved for any indication or in advanced clinical development.